aspirin_TS_487964117 A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk. Use of low-dose aspirin after a diagnosis of prostate ...
Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC) ...
Automated Extraction of Tumor Staging and Diagnosis Information From Surgical Pathology Reports Prostate cancer (PCa) is among the leading causes of cancer deaths. While localized PCa has a 5-year ...
Beta-blocker use by men with high-risk or metastatic prostate cancer (PCa) is associated with a decreased risk of PCa-specific mortality, a new study suggests. The study, led by Kristin Austlid Taskén ...
Researchers shed light on cutting-edge advances of AI in diagnosis, treatment, patient prognosis prediction, and molecular subtyping of PCa. Cancer is a significant global health issue affecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results